A physician orders a basic metabolic panel. Behind that single click, a laboratory information system, interface middleware, an electronic health record, and a web of terminology mappings must agree, code for code and unit for unit, on what “potassium, serum” means. Most of the time this agreement is invisible. When it is not, the failure is filed under a deliberately bland word—an “exception”—that can range from a transposed digit to a positive culture for a reportable pathogen that never gets flagged, because a local code was never mapped to a standard concept.

Most exceptions never matter. A duplicate result a technologist discards, a message that gets retried a second later and quietly succeeds—these are the background noise of running a laboratory, not a research problem. This paper cares about a narrower and more consequential slice: laboratory data exceptions that can turn into patient-safety or public-health events. What separates them from the background noise isn’t how alarming they look the moment they’re detected, but their propagation potential, meaning whether an exception left unresolved can reach a clinician’s decision or a public-health case count before anyone notices. A 2024 case report tracing real laboratory transmissions across a health information exchange found exactly this failure mode in practice [1]: specimen source missing, units and reference ranges inconsistent, coding discordant, HL7 versions clashing. Separately, the FDA’s Systemic Harmonization and Interoperability Enhancement for Laboratory Data (SHIELD) initiative [2] and a 2024 federal data brief [3] each identify laboratory-data harmonization as unresolved and consequential for patient safety and surveillance alike.

The central move in this paper is to stop treating a laboratory interoperability exception as a bare technical failure and start treating it as a risk signal. The AI does not predict clinical abnormalities or diagnose the patient; it recognizes irregularities in the data and workflow surrounding a result—an unmapped code, a malformed message, an identity mismatch—and assigns each one a risk score describing what would happen if it propagated into clinical care or public-health reporting. AI-LEx performs this transformation by combining four capabilities: deterministic validation and machine-learning anomaly detection to catch the irregularity, semantic knowledge to explain it, and human-governed resolution to act on it safely. Cutting any one of these four leaves the transformation incomplete—validation alone cannot explain what it catches, semantic knowledge alone cannot decide when to act, and neither is safe to act on without a human able to intervene—and this is the paper’s organizing contribution.

Can an AI-driven,interoperable laboratory exception-management architecture detect,classify,explain,prioritize,and resolve laboratory data exceptions across healthcare and public-health systems before they create patient-safety or public-health risk?

Section 2 reviews related work in three areas. Section 3 states the resulting research gap and four research questions. Section 4 presents the AI-LEx architecture across four diagrams. Section 5 describes a synthetic experimental design, and Section 6 reports its results. Sections 7 and 8 discuss patient-safety and public-health implications and the architecture’s limitations, and Section 9 concludes.

Point-specific AI models for pre-analytical error detection exist and perform well within narrow scope. Semantic interoperability standards exist and are mature, if unevenly adopted. Public-health reporting channels exist and are being modernized toward FHIR. What does not widely exist is an architecture that unifies detection, semantic grounding, risk-aware prioritization, and human governance into one auditable pipeline that treats an exception’s full lifecycle as a single continuous problem rather than a series of handoffs between separate systems. This gap motivates four research questions:

RQ1—Can a hybrid architecture combining deterministic rules, calibrated ML, and knowledge-grounded generation detect and classify laboratory data/workflow exceptions more effectively than any single method alone?RQ2—Can risk and AI confidence be computed as independent signals and combined through an explicit decision matrix to reduce false positives without sacrificing recall on high-risk cases?RQ3—What architectural mechanisms keep such a system auditable and appropriately human-governed rather than autonomously making irreversible decisions?RQ4—Can this architecture’s design plausibly address the categories of interoperability failure already documented empirically in real laboratory-to-EHR data transmissions?

Section 4 proposes an architecture addressing all three of RQ1 - RQ3, but only RQ1 receives empirical evaluation in this paper, in Sections 5 and 6; RQ2 and RQ3 are addressed at the level of architectural design and remain to be tested empirically. RQ4 is addressed by direct reference to the empirical failure modes reviewed in Section 2.1.

Each of AI-LEx’s four defining capabilities has a home in the sections below: deterministic validation and machine-learning anomaly detection are realized in Stage A, and semantic knowledge in Stage B—both within Section 4.2—and human-governed resolution in Stage C (Section 4.3), where a risk score is finally attached to what Stage A and B detected and explained. AI-LEx is presented across four diagrams rather than one increasingly overloaded picture: an overall pipeline view, the AI detection and reasoning mechanism, the risk and resolution mechanism that performs this paper’s central transformation, and the end-to-end workflow that ties them together.

No real-world labeled corpus of laboratory exceptions was available for this paper, and we make no claim to clinical validation. Instead, we report a synthetic, illustrative evaluation designed to test a narrow, falsifiable version of RQ1: whether combining independent detection channels outperforms any single channel, on data constructed so that no single channel has access to all the signal that determines ground truth. To be explicit about scope: Sections 5 and 6 evaluate RQ1 only. RQ2’s decision mechanism (Section 4.3) is a proposed design, not an evaluated one—doing so would require risk-category ground truth, confidence-threshold behavior, and outcomes for each of the five decision-matrix actions, none of which this binary-detection experiment constructs. We limit our empirical claims to RQ1 accordingly and return to this scope explicitly in Section 6.

Figure 3. Risk and resolution: risk and confidence computed independently, combined only at the decision matrix.

Figure 4. End-to-end workflow: a shared twelve-step pipeline with an auto-resolution shortcut, an escalation path, and six exception types assigned once at classification.

Before presenting the synthetic labels, it is worth being precise about what they represent. Following the propagation-potential criterion introduced in Section 1, we define a genuine actionable exception as one that, left unresolved, would either alter or delay a clinical decision or cause a case to fail to surface for public-health reporting when it should have. This is deliberately a criterion about downstream consequence, not about how alarming or unusual the underlying anomaly looks now it is flagged. A routine technical exception—a duplicate message that resolves itself on retry, a cosmetic formatting mismatch with no bearing on interpretation—fails this criterion even if it trips a system-level alert, because nothing downstream would change if it went unaddressed. An actionable interoperability event, by contrast, is one where that downstream change is real: a code that stays unmapped, a specimen source that stays missing, a result that reaches a clinician or a surveillance system already wrong. Section 5.1 operationalizes exactly this distinction rather than a looser notion of “anomalous”.

Table 1 reports precision, recall, F1, and false positives for all four approaches on the synthetic held-out test set (n = 900; base rate of genuine exceptions 57.1%).

Table 1. Synthetic, illustrative evaluation results—not a clinical validation. AI-LEx (hybrid) row highlighted.

Rules-only achieved perfect precision (100.0%) but the lowest recall (16.1%, F1 = 0.278): deterministic conditions caught only the subset of exceptions their fixed logic was written for, exactly the failure mode Section 2.1’s empirical evidence describes—correct when it fires, silent otherwise. ML-only, using the calibrated probabilities described in Section 5.2, reached moderate performance (F1 = 0.621, precision 97.5%, recall 45.5%) and produced 6 of the evaluation’s false positives, consistent with a statistical classifier occasionally flagging borderline structured patterns that free text or hard rules would not. The LLM/RAG-proxy performed better than single structured method (F1 = 0.833) with zero false positives, reflecting that this synthetic dataset’s text channel was a comparatively clean signal—a property of the synthetic generator, not a general claim about retrieval-based methods. AI-LEx (hybrid) achieved the highest recall (97.9%) and F1 (0.983) of all four approaches, inheriting ML-only’s 6 false positives unchanged, since the hybrid decision rule flags a case if any channel does.

This pattern is consistent with RQ1 as posed: because the dataset’s ground truth was constructed so that no single channel sees all the signal, no single-channel method could recover more than a fraction of true exceptions, while an OR-combined detector drawing on all three channels recovered nearly all of them. The false-positive count carried over unchanged from ML-only to the hybrid is itself informative: it shows that combining channels here improved recall without a corresponding recall-driven increase in false positives—the hybrid rule did not add new false positives beyond what its noisiest single channel already produced. We are deliberately narrow about what this shows: an OR-combined detector performs well under a generator designed around independent channel signals. It does not demonstrate the general logical necessity of hybrid detection in operational laboratory data, where channels may be correlated, noisier, or informative in ways this synthetic construction does not capture. We return to this distinction, and to what would be required to test it on real data, in Section 8.

For patient safety, the architecture’s contribution is not that it catches more exceptions than existing point solutions—several detection techniques already exist individually—but that every exception it surfaces already carries a clinically meaningful risk signal rather than a bare technical flag and is resolved automatically only when that signal says it is safe to do so. Alert fatigue is a well-documented hazard in clinical informatics, and a system that surfaces only the exceptions genuinely requiring human judgment, each with a specific, ontology-grounded rationale and an explicit risk score attached, is more likely to receive the attention it needs than one that treats every anomaly as equally urgent. Reducing time-to-resolution matters most exactly where speed is clinically important: critical values, unstable patients, and reportable pathogens.

For public health, the architecture targets a specific and under-appreciated cause of underreporting: cases that are clinically identified but never surface for public-health review because of a semantic mapping gap rather than any failure of clinical judgment, precisely the failure mode documented in the 2024 case report reviewed in Section 2.1. Because AI-LEx assigns a public-health-impact term inside the Risk Score itself, a mapping gap on a reportable organism does not merely fail silently—it is surfaced as a publicly meaningful risk signal before it reaches the reporting layer, reducing the number of cases that fail to reach surveillance systems and improving reporting speed, which matters disproportionately during an active outbreak.

Three limitations qualify every claim in this paper. First, and most importantly, Sections 5 and 6 report a synthetic, illustrative evaluation of RQ1 only, not a clinical validation and not a test of RQ2 or RQ3: the dataset was constructed by the authors specifically so that no single channel could recover the full label, which shows that an OR-combined detector outperforms any single channel under this generator but cannot estimate real-world precision, recall, or false-positive rates on genuine laboratory data, and says nothing yet about whether the proposed risk/confidence decision matrix (RQ2) performs as intended. Second, the “LLM/RAG-proxy” baseline is a bag-of-words classifier standing in for a retrieval/LLM-style method; no live large-language-model inference was run, and a real RAG pipeline’s performance on this task remains untested. Third, a newly deployed system’s exception knowledge graph starts empty, and whether federating generalized error patterns across institutions—without pooling identifiable data—can close this cold-start gap without eroding the specificity that makes the knowledge graph useful is an open empirical question this paper does not resolve.

The clear next step is validating this architecture against a real, labeled corpus of laboratory exceptions, ideally spanning multiple institutions, replacing the text-classifier proxy with an actual retrieval-augmented LLM pipeline—an approach recent work has begun applying directly to automated construction of clinical knowledge graphs [20]—and prospectively measuring alert-fatigue outcomes among reviewing clinicians and laboratory staff rather than relying on the synthetic false-positive count reported here. Evaluating RQ2 and RQ3 empirically is a separate and necessary undertaking beyond what this paper attempts: it requires risk-category ground truth, confidence-threshold behavior under realistic model uncertainty, and outcome data for each of the five decision-matrix actions in Figure 3, none of which the binary-detection experiment in Sections 5 and 6 was designed to produce.

This paper set out to argue for a specific reframing: a laboratory interoperability exception is not a bare technical failure but a risk signal waiting to be recognized as one and recognizing it that way takes four things working together—deterministic validation, machine-learning anomaly detection, semantic knowledge, and human-governed resolution. Sections 4 through 7 developed each of those four capabilities in turn and showed how they compose: validation and anomaly detection catch what a rules engine or a classifier alone would miss between them; semantic knowledge turns a bare flag into an explanation; and human-governed resolution, guided by a risk score kept strictly independent of the AI’s own confidence, decides what happens next—never the AI unilaterally. The synthetic evaluation in Section 6 gave the first part of that argument, hybrid detection over any single method, a first illustrative empirical test (F1 of 0.983 against 0.278 - 0.833), and Section 8 was plain that this is a demonstration on constructed data, not a clinical finding. What we believe holds regardless of that limitation is narrower and, we think, worth building toward: that a laboratory exception is never just a technical failure, that recognizing it as a risk signal requires all four capabilities rather than any one alone, and that keeping an AI system’s confidence in itself separate from its assessment of danger is not a detail but the discipline that makes such a system safe to deploy at all.